NCT04324853

Brief Summary

Purpose: To examine whether helminth infection during pregnancy alters Vitamin-D-metabolism and reactivity of the child's immune system Hypothesis: Helminth infection during pregnancy is associated with altered Vitamin D levels and Vitamin D receptor expression in the placenta and modified immune reactivity in the infant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 28, 2019

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 25, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 27, 2020

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

June 18, 2023

Status Verified

April 1, 2023

Enrollment Period

3.9 years

First QC Date

March 25, 2020

Last Update Submit

June 16, 2023

Conditions

Keywords

PregnancyVitamin DHelminthSchistosomiasis

Outcome Measures

Primary Outcomes (1)

  • Association between Schistosoma and helminth infection and Vitamin D levels.

    Schistosoma hematobium in pregnancy is associated with vitamin D metabolism

    48 Months

Secondary Outcomes (1)

  • Association between Schistosoma infection and intrauterine growth restriction (IUGR) (defined as birth weight below the 10th birth weight percentile), stillbirth and premature delivery.

    48 Months

Study Arms (3)

S. haematobium positive

Pregnant women infected with Schistosoma hematobium alone

Diagnostic Test: Microscopy ( Urine filtration), UCAA test, qPCR,

geohelminths positive

pregnant women infected with geohelminths alone

Diagnostic Test: Microscopy (Kato Katz, Coproculture, Harada Mori, MIF), qPCR,

Helminth negative

Pregnant women free of anyn helminths infection

Diagnostic Test: Microscopy (Kato Katz, Coproculture, Harada Mori, MIF), qPCR,

Interventions

Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes (trematode worms) of the genus Schistosoma.Schistosomiasis is prevalent in tropical and subtropical areas, especially in poor communities without access to safe drinking water and adequate sanitation.

S. haematobium positive

Soil-transmitted helminth infections are among the most common infections worldwide and affect the poorest and most deprived communities. They are transmitted by eggs present in human faeces which in turn contaminate soil in areas where sanitation is poor.

Helminth negativegeohelminths positive

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The target population is pregnant women coming to the ante natal clinics (ANC) for routine visits or to obtain medical care in the obstetrics department of the Albert Schweitzer Hospital (ASH) as well as at Georges Rawiri General Hospital (GRGH), both situated in Lambaréné. The pregnant women originally from areas endemic for Schistosomiasis and Soil-transmitted helminths will be invited to participate into the study.

You may qualify if:

  • Pregnant women attending antenatal care from Lambaréné and Fougamou areas
  • Pregnant women who have given written informed consent to the study for herself and for her unborn child and live infant.

You may not qualify if:

  • Known of chronic infections and diseases(e.g. diabetes, HIV, Hepatitis B and C, anemia).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Josiane Y Honkpehedji

Lambaréné, Moyen-Ogooué Province, BP 242, Gabon

Location

Biospecimen

Retention: SAMPLES WITH DNA

S. haematobium will be assessed using urine filtration technique, intestinal parasites will be determined using the Kato-Katz method as well as different culture methods According to their infection status, women will be allocated to the following groups: S. haematobium positive, geohelminths positive and helminth negative participants. Plasma and peripheral blood mononuclear cells (PBMCs) are prepared and stored at -150°C; serum will be collected and immediately frozen in lightproof vials at -80 °C until further analysis.

MeSH Terms

Conditions

Vitamin D DeficiencySchistosomiasis

Interventions

Microscopy

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic DiseasesTrematode InfectionsHelminthiasisParasitic DiseasesInfectionsVector Borne Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Ayola A ADEGNIKA, MD, PhD

    Centre de Recherche Médicale de Lambaréné

    PRINCIPAL INVESTIGATOR
  • Meral Esen, MD

    University Hospital Tuebingen

    STUDY CHAIR
  • Clarissa DaCosta, MD

    Technical University of Munich

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2020

First Posted

March 27, 2020

Study Start

January 28, 2019

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

June 18, 2023

Record last verified: 2023-04

Locations